LENSAR (NASDAQ:LNSR) Issues Earnings Results

LENSAR (NASDAQ:LNSRGet Free Report) released its quarterly earnings results on Thursday. The company reported ($0.19) earnings per share for the quarter, Zacks reports. LENSAR had a negative net margin of 34.11% and a negative return on equity of 40.53%. The firm had revenue of $10.59 million for the quarter.

LENSAR Price Performance

NASDAQ:LNSR traded down $0.04 during trading hours on Friday, hitting $3.78. 50,743 shares of the stock traded hands, compared to its average volume of 28,899. The stock has a 50 day moving average price of $3.53 and a 200 day moving average price of $3.34. LENSAR has a 1 year low of $1.80 and a 1 year high of $5.30.

Analysts Set New Price Targets

Separately, Lake Street Capital initiated coverage on LENSAR in a research report on Tuesday, March 19th. They issued a “buy” rating and a $8.00 price target for the company.

View Our Latest Report on LENSAR

About LENSAR

(Get Free Report)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Featured Stories

Earnings History for LENSAR (NASDAQ:LNSR)

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.